These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23203758)

  • 1. Structure-activity studies of lGnRH-III through rational amino acid substitution and NMR conformational studies.
    Pappa EV; Zompra AA; Diamantopoulou Z; Spyranti Z; Pairas G; Lamari FN; Katsoris P; Spyroulias GA; Cordopatis P
    Biopolymers; 2012; 98(6):525-34. PubMed ID: 23203758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lGnRH-III -- a promising candidate for anticancer drug development.
    Manea M; Mező G
    Protein Pept Lett; 2013 Apr; 20(4):439-49. PubMed ID: 23016589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives.
    Mezo G; Czajlik A; Manea M; Jakab A; Farkas V; Majer Z; Vass E; Bodor A; Kapuvári B; Boldizsár M; Vincze B; Csuka O; Kovács M; Przybylski M; Perczel A; Hudecz F
    Peptides; 2007 Apr; 28(4):806-20. PubMed ID: 17254668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity study on the LH- and FSH-releasing and anticancer effects of gonadotropin-releasing hormone (GnRH)-III analogs.
    Kovács M; Vincze B; Horváth JE; Seprodi J
    Peptides; 2007 Apr; 28(4):821-9. PubMed ID: 17289216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the central region of lamprey gonadotropin-releasing hormone III in the inhibition of breast cancer cell growth.
    Herédi-Szabó K; Lubke J; Toth G; Murphy RF; Lovas S
    Peptides; 2005 Mar; 26(3):419-22. PubMed ID: 15652648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is lGnRH-III the most potent GnRH analog containing only natural amino acids that specifically inhibits the growth of human breast cancer cells?
    Herédi-Szabó K; Murphy RF; Lovas S
    J Pept Sci; 2006 Nov; 12(11):714-20. PubMed ID: 16967433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.
    Hegedüs R; Manea M; Orbán E; Szabó I; Kiss E; Sipos E; Halmos G; Mező G
    Eur J Med Chem; 2012 Oct; 56():155-65. PubMed ID: 22967796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor.
    Montagnani Marelli M; Manea M; Moretti RM; Marzagalli M; Limonta P
    Int J Oncol; 2015 Jan; 46(1):243-53. PubMed ID: 25351635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal changes of brain GnRH-I, -II, and -III during the final reproductive period in adult male and female sea lamprey.
    Sower SA; Balz E; Aquilina-Beck A; Kavanaugh SI
    Gen Comp Endocrinol; 2011 Jan; 170(2):276-82. PubMed ID: 20709062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships.
    Mezö I; Lovas S; Pályi I; Vincze B; Kálnay A; Turi G; Vadász Z; Seprödi J; Idei M; Tóth G; Gulyás E; Otvös F; Mák M; Horváth JE; Teplán I; Murphy RF
    J Med Chem; 1997 Oct; 40(21):3353-8. PubMed ID: 9341910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate.
    Leurs U; Lajkó E; Mező G; Orbán E; Öhlschläger P; Marquardt A; Kőhidai L; Manea M
    Eur J Med Chem; 2012 Jun; 52():173-83. PubMed ID: 22480495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of synthetic lamprey GnRH-III on gonadotropin release and steroid hormone levels in gilts.
    Brüssow KP; Schneider F; Tuchscherer A; Kanitz W
    Theriogenology; 2010 Dec; 74(9):1570-8. PubMed ID: 20708243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of proopiomelanotropin and proopiocortin gene expression and of immunohistochemistry for gonadotropin-releasing hormones (lGnRH-I and III) during the life cycle of a nonparasitic lamprey: relationship to this adult life history type.
    Youson JH; Heinig JA; Khanam SF; Sower SA; Kawauchi H; Keeley FW
    Gen Comp Endocrinol; 2006 Aug; 148(1):54-71. PubMed ID: 16364323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that lamprey GnRH-III does not release FSH selectively in cattle.
    Amstalden M; Zieba DA; Garcia MR; Stanko RL; Welsh TH; Hansel WH; Williams GL
    Reproduction; 2004 Jan; 127(1):35-43. PubMed ID: 15056768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on chemotactic drug targeting (chemotaxis and adhesion) inducer effect of GnRH-III derivatives in Tetrahymena and human leukemia cell line.
    Lajkó E; Szabó I; Andódy K; Pungor A; Mező G; Kőhidai L
    J Pept Sci; 2013 Jan; 19(1):46-58. PubMed ID: 23208929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs.
    Pappa EV; Zompra AA; Spyranti Z; Diamantopoulou Z; Pairas G; Lamari FN; Katsoris P; Spyroulias GA; Cordopatis P
    Biopolymers; 2011; 96(3):260-72. PubMed ID: 20632397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational space comparison of GnRH and lGnRH-III using molecular dynamics, cluster analysis and Monte Carlo thermodynamic integration.
    Watts CR; Mezei M; Murphy RF; Lovas S
    J Biomol Struct Dyn; 2001 Apr; 18(5):733-48. PubMed ID: 11334110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization and kinetic studies of an ancestral lamprey GnRH-III selective type II GnRH receptor from the sea lamprey, Petromyzon marinus.
    Silver MR; Sower SA
    J Mol Endocrinol; 2006 Jun; 36(3):601-10. PubMed ID: 16720727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites.
    Orbán E; Mezo G; Schlage P; Csík G; Kulić Z; Ansorge P; Fellinger E; Möller HM; Manea M
    Amino Acids; 2011 Jul; 41(2):469-83. PubMed ID: 20953647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4.
    Manea M; Leurs U; Orbán E; Baranyai Z; Öhlschläger P; Marquardt A; Schulcz Á; Tejeda M; Kapuvári B; Tóvári J; Mezo G
    Bioconjug Chem; 2011 Jul; 22(7):1320-9. PubMed ID: 21668011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.